FDA 483 - Becton Dickinson & Company - March 17, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Becton Dickinson & Company in Franklin Lakes, NJ, from February 3 to March 17, 2020, revealed significant deficiencies in quality system procedures. The firm failed to adequately establish complaint handling procedures and submit Medical Device Reports (MDRs) within the required timeframe, both of which were repeat observations. Additionally, the inspection found that sampling methods for quality control were not adequately established or documented.
ID · c6a62f01-d862-44c6-856a-72cb5dbc1495